We use cookies for a better user experience. Read our Privacy Policy

I Agree

Aptamer Market Outlook, 2017-2025

Aptamer Market (Material - Nucleic acid Aptamer, Peptide Aptamer; Selection Technique - SELEX Technique and Others; Application - Research, Diagnostics, Therapeutics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Aptamer Market: Outlook

The corporate survey study by the Transparency Market Research projects that the global aptamer market will showcase a brilliant growth rate of 20 % during the forecast period for the study, i.e. 2017 to 2025. It also predicts that the global aptamer market will expand from its initial evaluation to surpass the value of US$ 5 billion at the end of the forecast period. Some of the major drivers for the development in the global aptamer market include constant advancements in the technologies intended for selection of proper aptamer as well as the rising focus by several industry players on research and development.

Furthermore, benefits and features provided by the solutions in the global aptamer market such as cost effectiveness as well as high thermal stability are anticipated to fast track the adoption of the products within the industry. On the other hand, dearth of regulatory guidelines pertaining to development of molecules as well as the negative side effects of using aptamers may restrict the growth within the global aptamer market in coming years. However, constant efforts on development of novel aptamers intended for usage in a number of medical applications is bound to foster the development in the global aptamer market in coming years. The segments in the global aptamer market based on the material are peptide aptamer as well as nucleic acid aptamer.

global aptamer market

SELEX Selection Technique Segment Takes Lead in Aptamer Market

Segments in the global aptamer market by the technique used are MARAS and SELEX techniques, among others. Based by the technique of selection, the SELEX technique is expected to dominate the global aptamer market over the forecast period. This trend can be attributed to the rising focus on advancing the SELEX technique by diversification into novel techniques such as M-SELEX as well as CE-SELEX.

Some of the key applications for the products and solutions provided by the manufacturers and players within the global aptamer market include diagnostics, research, and therapeutics, among others. The segment of research dominated the application segments in the global aptamer market in recent past and is also expected to remain dominant in the global aptamer market throughout the forecast years. This trend can be attributed to the rising investments by players in the global aptamer market intended for research and development. The diagnostics segment also accounted for a high share in the global aptamer market, owing to medical advancements such as effective ADME or adsorption, distribution, metabolism, and excretion properties.

Major regions and leading economies assessed thoroughly in the business intelligence study on the global aptamer market include Europe (including Germany, Italy, the United Kingdom, France, Spain, and rest of the Europe), Latin America (including Brazil, Mexico, and rest of the Latin America), North America (including the United States and Canada), Asia Pacific (including Japan, Australia and New Zealand, China, India, and rest of the Asia Pacific), Middle East and Africa (including the Gulf Cooperation Council countries, South Africa, and rest of the Middle East and Africa), and rest of the World. Among these, the North America region led the global aptamer market in recent past, owing to rising investments from various regional players.

Players in the Aptamer Market Focused on Furthering R & D

Few of the most prominent players covered within the business intelligence report on the global aptamer market include Aptagen, LLC, Aptamer Sciences, Inc., CD Genomics, NAXXON Pharma, TriLink BioTechnologies, LLC, Pfizer, Inc., AM Biotech, Aptamer Group, Base Pair Biotechnologies, NeoVentures Biotechnology, Inc., and Aptus Biotech, among others. Players in the global aptamer market are heavily investing in research and development activities in order to diversify the scope of applications for the aptamer molecules. Furthermore, several companies operating within the global aptamer market are also engaged in corporate advancement moves such as mergers and acquisitions.

The global aptamer market has been segmented as follows:

Material

  • Nucleic acid Aptamer
  • Peptide Aptamer

Technique

 

  • SELEX Technique
  • Others (MARAS, etc.)

Application

  • Research
  • Diagnostics
  • Therapeutics
  • Others

Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Rest of World

Frequently Asked Questions

What is the total market worth of Aptamer Market?

The global aptamer market was valued at approximately US$ 1.0 Bn in 2016 and is anticipated to reach at a US$ 5.0 Billion By 2025

What is the anticipated CAGR of the Aptamer Market in the forecast period?

Aptamer Market is anticipated to grow at a CAGR of 20.9% during the forecast period

Which region is expected to project the highest market share in the global Aptamer Market?

North America accounted for a major share of the global Aptamer Market

What are the key driving factors for the growth of the Aptamer market?

Drivers for the development in the global aptamer market include constant advancements in the technologies intended for selection of proper aptamer as well as the rising focus by several industry players on research and development.

Who are the key players in the global Aptamer Market?

Key players in the global Aptamer Market include Aptagen, LLC, Aptamer Sciences, Inc., CD Genomics, NAXXON Pharma, TriLink BioTechnologies, LLC, Pfizer, Inc., AM Biotech, Aptamer Group, Base Pair Biotechnologies, NeoVentures Biotechnology, Inc., and Aptus Biotech

    Chapter 1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

    Chapter 2. Assumptions and Research Methodology

    Chapter 3. Executive Summary : Global Aptamer Market 

    Chapter 4. Market Overview
    4.1. Introduction
           4.1.1. Product Overview
           4.1.2. Industry Evolution / Developments
    4.2. Market Dynamics 
           4.2.1. Drivers
           4.2.2. Restraints
           4.2.3. Opportunities
    4.3. Pipeline Analysis – Aptamer Market
    4.4. Porter’s Five Force Representation
    4.5. Global Aptamer Market Analysis and Forecasts, 2015-2025
           4.5.1. Market Revenue Projection (US$ Mn)
           4.5.2. Market Outlook
    4.6. Key Trends

    Chapter 5. Global Aptamer Market Analysis and Forecasts, By Material Type 
    5.1. Key Findings / Developments
    5.2. Introduction & Definition
    5.3. Market Value Forecast By Material Type, 2016–2025
           5.3.1. Nucleic acid Aptamer
           5.3.2. Peptide Aptamer
    5.4. Market Attractiveness By Material Type

    Chapter 6. Global Aptamer Market Analysis and Forecasts, By Selection Technique
    6.1. Key Findings / Developments
    6.2. Introduction & Definition
    6.3. Market Value and Volume Forecast By Selection Technique, 2016–2025
           6.3.1. SELEX Technique
           6.3.2. Others
    6.4. Market Attractiveness By Selection Technique

    Chapter 7. Global Aptamer Market Analysis and Forecasts, By Application
    7.1. Key Findings / Developments
    7.2. Introduction & Definition
    7.3. Market Value and Volume Forecast By Application, 2017–2025
           7.3.1. Research
           7.3.2. Diagnostics
           7.3.3. Therapeutics
           7.3.4. Others
    7.4. Market Attractiveness By Application

    Chapter 8. Global Aptamer Market Analysis and Forecasts, By Geography/Region 
    8.1. Geographical Representation
    8.2. Market Value and Volume Forecast By Region
           8.2.1. North America 
           8.2.2. Europe 
           8.2.3. Asia Pacific 
           8.2.4. Latin America 
           8.2.5. Rest of World 
    8.3. Market Attractiveness By Region
    8.4. Key Trends

    Chapter 9. North America Aptamer Market Analysis and Forecast 
    9.1. Market Value Forecast By Country , 2017–2025
           9.1.1. U.S.
           9.1.2. Canada
    9.2. Market Value Forecast By Material Type, 2016–2025
    9.3. Market Value Forecast By Selection Technique, 2016–2025
    9.4. Market Value Forecast By Application, 2016-2025
    9.5. Market Attractiveness Analysis
           9.5.1. By Country
           9.5.2. By Material Type
           9.5.3. By Selection Technique
           9.5.4. By Application
    9.6. Key Trends

    Chapter 10. Europe Aptamer Market Analysis and Forecast 
    10.1. Market Value Forecast By Country , 2017–2025
           10.1.1. Germany
           10.1.2. France
           10.1.3. U.K.
           10.1.4. Spain
           10.1.5. Italy
           10.1.6. Rest of Europe
    10.2. Market Value Forecast By Material Type, 2016–2025
    10.3. Market Value Forecast By Selection Technique, 2016–2025
    10.4. Market Value Forecast By Application, 2016-2025
    10.5. Market Attractiveness Analysis
           10.5.1. By Country
           10.5.2. By Material Type
           10.5.3. By Selection Technique
           10.5.4. By Application
    10.6. Key Trends

    Chapter 11. Asia Pacific Aptamer Market Analysis and Forecast 
    11.1. Market Value Forecast By Country , 2017–2025
           11.1.1. China       
           11.1.2. Japan
           11.1.3. India
           11.1.4. Australia & New Zealand
           11.1.5. Rest of APAC
    11.2. Market Value Forecast By Material Type, 2016–2025
    11.3. Market Value Forecast By Selection Technique, 2016–2025
    11.4. Market Value Forecast By Application, 2016-2025
    11.5. Market Attractiveness Analysis
           11.5.1. By Country
           11.5.2. By Material Type
           11.5.3. By Selection Technique
           11.5.4. By Application
    11.6. Key Trends

    Chapter 12. Latin America Aptamer Market Analysis and Forecast 
    12.1. Market Value Forecast By Country, 2017–2025
           12.1.1. Brazil
           12.1.2. Mexico
           12.1.3. Rest of LATAM
    12.2. Market Value Forecast By Material Type, 2016–2025
    12.3. Market Value Forecast By Selection Technique, 2016–2025
    12.4. Market Value Forecast By Application, 2016-2025
    12.5. Market Attractiveness Analysis
           12.5.1. By Country
           12.5.2. By Material Type
           12.5.3. By Selection Technique
           12.5.4. By Application
    12.6. Key Trends

    Chapter 13. Rest of World Aptamer Market Analysis and Forecast 
    13.1. Market Value Forecast By Material Type, 2016–2025
    13.2. Market Value Forecast By Selection Technique, 2016–2025
    13.3. Market Value Forecast By Application, 2016-2025
    13.4. Market Attractiveness Analysis
           13.4.1. By Material Type
           13.4.2. By Selection Technique
           13.4.3. By Application
    13.5. Key Trends

    Chapter 14. Competition Landscape
    14.1. Competition Matrix
    14.2. Company Profiles
           14.2.1. AM Biotech. (HQ, Business Segments, Employee Strength)
                     14.2.1.1. Company Details
                     14.2.1.2. Company Description
                     14.2.1.3. Business Overview
                     14.2.1.4. SWOT Analysis
                     14.2.1.5. Financial Analysis
                     14.2.1.6. Strategic Overview
           14.2.2. Aptagen, LLC. (HQ, Business Segments, Employee Strength)
                     14.2.2.1. Company Details
                     14.2.2.2. Company Description
                     14.2.2.3. Business Overview
                     14.2.2.4. SWOT Analysis
                     14.2.2.5. Strategic Overview
           14.2.3. Aptamer Group (HQ, Business Segments, Employee Strength)
                     14.2.3.1. Company Details
                     14.2.3.2. Company Description
                     14.2.3.3. Business Overview
                     14.2.3.4. SWOT Analysis
                     14.2.3.5. Strategic Overview
           14.2.4. Aptamer Science, Inc. (HQ, Business Segments, Employee Strength)
                     14.2.4.1. Company Details
                     14.2.4.2. Company Description
                     14.2.4.3. Business Overview
                     14.2.4.4. SWOT Analysis
                     14.2.4.5. Strategic Overview
           14.2.5. Pfizer Inc. (HQ, Business Segments, Employee Strength)
                     14.2.5.1. Company Details
                     14.2.5.2. Company Description
                     14.2.5.3. Business Overview
                     14.2.5.4. SWOT Analysis
                     14.2.5.5. Financial Analysis
                     14.2.5.6. Strategic Overview
           14.2.6. Base Pair Biotechnologies (HQ, Business Segments, Employee Strength)
                     14.2.6.1. Company Details
                     14.2.6.2. Company Description
                     14.2.6.3. Business Overview
                     14.2.6.4. SWOT Analysis
                     14.2.6.5. Financial Analysis
                     14.2.6.6. Strategic Overview
           14.2.7. CD Genomics (HQ, Business Segments, Employee Strength)
                     14.2.7.1. Company Details
                     14.2.7.2. Company Description
                     14.2.7.3. Business Overview
                     14.2.7.4. SWOT Analysis
                     14.2.7.5. Financial Analysis
                     14.2.7.6. Strategic Overview
           14.2.8. NeoVentures Biotechnology Inc. (HQ, Business Segments, Employee Strength)
                     14.2.8.1. Company Details
                     14.2.8.2. Company Description
                     14.2.8.3. Business Overview
                     14.2.8.4. SWOT Analysis
                     14.2.8.5. Financial Analysis
                     14.2.8.6. Strategic Overview
           14.2.9. NAXXON Pharma (HQ, Business Segments, Employee Strength)
                     14.2.9.1. Company Details
                     14.2.9.2. Company Description
                     14.2.9.3. Business Overview
                     14.2.9.4. SWOT Analysis
                     14.2.9.5. Strategic Overview
           14.2.10. Aptus Biotech (HQ, Business Segments, Employee Strength)
                     14.2.10.1. Company Details
                     14.2.10.2. Company Description
                     14.2.10.3. Business Overview
                     14.2.10.4. SWOT Analysis
                     14.2.10.5. Strategic Overview
           14.2.11. TriLink Bio Technologies, LLC (HQ, Business Segments, Employee Strength)
                     14.2.11.1. Company Details
                     14.2.11.2. Company Description
                     14.2.11.3. Business Overview
                     14.2.11.4. SWOT Analysis
                     14.2.11.5. Strategic Overview  

    List of Tables

    Table 01: Revenue Share (A), 2016
    Table 02: Revenue Share (B), 2016
    Table 03: Aptamer Based Drugs Pipeline Analysis
    Table 04: Global Aptamer Market Size (US$ Mn) Forecast, by Material Type, 2015–2025
    Table 05: Global Aptamer Market Size (US$ Mn) Forecast, by Selection Technique, 2015–2025
    Table 06: Global Aptamer Market Size (US$ Mn) Forecast, by Application, 2015–2025
    Table 07: Global Aptamer Market Size (US$ Mn) Forecast, by Region, 2015–2025
    Table 08: North America Aptamer Market Size (US$ Mn) Forecast, by Country, 2015–2025
    Table 09: North America Aptamer Market Size (US$ Mn) Forecast, by Material Type, 2015–2025
    Table 10: North America Aptamer Market Size (US$ Mn) Forecast, by Selection Technique, 2015–2025
    Table 11: North America Aptamer Market Size (US$ Mn) Forecast, by Application, 2015–2025
    Table 12: Europe Aptamer Market Size (US$ Mn) Forecast, by Country, 2015–2025
    Table 13: Europe Aptamer Market Size (US$ Mn) Forecast, by Material Type, 2015–2025
    Table 14: Europe Aptamer Market Size (US$ Mn) Forecast, by Selection Technique, 2015–2025
    Table 15: Europe Aptamer Market Size (US$ Mn) Forecast, by Application, 2015–2025
    Table 16: Asia Pacific Aptamer Market Size (US$ Mn) Forecast, by Country, 2015–2025
    Table 17: Asia Pacific Aptamer Market Size (US$ Mn) Forecast, by Material Type, 2015–2025
    Table 18: Asia Pacific Aptamer Market Size (US$ Mn) Forecast, by Selection Technique, 2015–2025
    Table 19: Asia Pacific Aptamer Market Size (US$ Mn) Forecast, by Application, 2015–2025
    Table 20: Latin America Aptamer Market Size (US$ Mn) Forecast, by Country, 2015–2025
    Table 21: Latin America Aptamer Market Size (US$ Mn) Forecast, by Material Type, 2015–2025
    Table 22: Latin America Aptamer Market Size (US$ Mn) Forecast, by Selection Technique, 2015–2025
    Table 23: Latin America Aptamer Market Size (US$ Mn) Forecast, by Application, 2015–2025
    Table 24: Rest of World Aptamer Market Size (US$ Mn) Forecast, by Material Type, 2015–2025
    Table 25: Rest of World Aptamer Market Size (US$ Mn) Forecast, by Selection Technique, 2015–2025
    Table 26: Rest of World Aptamer Market Size (US$ Mn) Forecast, by Application, 2015–2025

    List of Figures

    Figure 01: Global Aptamer Market Snapshot
    Figure 02: Global Aptamer Market Size (US$ Mn) Forecast, 2015–2025
    Figure 03: Global Aptamer Y-o-Y Growth Rate (%), 2016–2025
    Figure 04: Global Aptamer Market Value Share, by Region (2016
    Figure 05: Global Aptamer Market Value Share, by Material Type (2016)
    Figure 06: Global Addiction Treatment Market Value Share, by Application (2016)
    Figure 07: Global Aptamer Market Value Share, by Selection Technique (2016)
    Figure 08:  Global Aptamer Market, by Material Type
    Figure 09: Global Aptamer Market Value Share Analysis, by Material Type, 2016 and 2025
    Figure 10: Global Aptamer Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Nucleic acid (DNA or RNA) Aptamer 2015–2025
    Figure 11: Global Aptamer Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Peptide Aptamer 2015–2025
    Figure 12: Global Aptamer Market Attractiveness Analysis, by Material Type
    Figure 13: Global Aptamer Market, by Selection Technique
    Figure 14: Global Aptamer Market Value Share Analysis, by Selection Technique, 2016 and 2025
    Figure 15: Global Aptamer Market Revenue (US$ Mn) and Y-o-Y Growth (%), by SELEX 2015–2025
    Figure 16: Global Aptamer Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others 2015–2025
    Figure 17: Global Aptamer Market Attractiveness Analysis, by Selection Technique
    Figure 18: Global Aptamer Market, by Application
    Figure 19: Global Aptamer Market, by Application
    Figure 20: Global Aptamer Market Value Share Analysis, by Application, 2016 and 2025
    Figure 21: Global Aptamer Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Research 2015–2025
    Figure 22: Global Aptamer Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostics 2015–2025
    Figure 23: Global Aptamer Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Therapeutics 2015–2025
    Figure 24: Global Aptamer Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others 2015–2025
    Figure 25: Global Aptamer Market Attractiveness Analysis, by Application
    Figure 26: Global Radiation Dose Management Market
    Figure 27: Global Aptamer Market Value Share Analysis, by Region, 2016 and 2025
    Figure 28: Global Aptamer Market Attractiveness Analysis, by Region
    Figure 29: North America Aptamer Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
    Figure 30: North America Aptamer Market Value Share, by Country, 2016 and 2025
    Figure 31: North America Aptamer Market Attractiveness, by Country, 2016–2025
    Figure 32: North America Aptamer Market Value Share, by Material Type, 2016 and 2025
    Figure 33: North America Aptamer Market Attractiveness, by Material Type, 2016–2025
    Figure 34: North America Aptamer Market Value Share, Selection Technique, 2016 and 2025
    Figure 35: North America Aptamer Market Attractiveness Analysis, Selection Technique, 2016–2025
    Figure 36: North America Aptamer Market Value Share, by Application, 2016 and 2025
    Figure 37: North America Aptamer Market Attractiveness Analysis, by Application, 2016–2025
    Figure 38: Europe Aptamer Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
    Figure 39: Europe Aptamer Market Value Share, by Country, 2016 and 2025
    Figure 40: Europe Aptamer Market Attractiveness, by Country, 2016–2025
    Figure 41: Europe Aptamer Market Value Share, by Material Type, 2016 and 2025
    Figure 42: Europe Addiction Treatment Market Attractiveness, by Material Type, 2016–2025
    Figure 43: Europe Aptamer Market Value Share, by Selection Technique, 2016 and 2025
    Figure 44: Europe Aptamer Market Attractiveness Analysis, by Selection Technique, 2016–2025
    Figure 45: Europe Aptamer Market Value Share, by Application, 2016 and 2025
    Figure 46: Europe Aptamer Market Attractiveness Analysis, by Application, 2016–2025
    Figure 47: Asia Pacific Aptamer Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
    Figure 48: Asia Pacific Aptamer Market Value Share, by Country, 2016 and 2025
    Figure 49: Asia Pacific Aptamer Market Attractiveness, by Country, 20176–2025
    Figure 50: Asia Pacific Aptamer Market Value Share, by Material Type, 2016 and 2025
    Figure 51: Asia Pacific Aptamer Market Attractiveness, by Material Type, 2016–2025
    Figure 52: Asia Pacific Aptamer Market Value Share, Selection Technique, 2016 and 2025
    Figure 53: Asia Pacific Aptamer Market Attractiveness Analysis, Selection Technique, 2016–2025
    Figure 54: Asia Pacific Aptamer Market Value Share, by Application, 2016 and 2025
    Figure 55: Asia Pacific Aptamer Market Attractiveness Analysis, by Application, 2016–2025
    Figure 56: Latin America Aptamer Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
    Figure 57: Latin America Aptamer Market Value Share, by Country, 2016 and 2025
    Figure 58: Latin America Aptamer Market Attractiveness, by Country, 2016–2025
    Figure 59: Latin America Aptamer Market Value Share, by Material Type, 2016 and 2025
    Figure 60: Latin America Aptamer Market Attractiveness, by Material Type, 2016–2025
    Figure 61: Latin America Aptamer Market Value Share, Selection Technique, 2016 and 2025
    Figure 62: Latin America Aptamer Market Attractiveness Analysis, Selection Technique, 2016–2025
    Figure 63: Latin America Aptamer Market Value Share, by Application, 2016 and 2025
    Figure 64: Latin America Aptamer Market Attractiveness Analysis, by Application, 2016–2025
    Figure 65: Rest of World Aptamer Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
    Figure 66: Rest of World Aptamer Market Value Share, by Material Type, 2016 and 2025
    Figure 67: Rest of World Aptamer Market Attractiveness, by Material Type, 2016–2025
    Figure 68: Rest of World Aptamer Market Value Share, Selection Technique, 2016 and 2025
    Figure 69: Rest of World Aptamer Market Attractiveness Analysis, Selection Technique, 2016–2025
    Figure 70: Rest of World Aptamer Market Value Share, by Application, 2016 and 2025
    Figure 71: Rest of World Aptamer Market Attractiveness Analysis, by Application, 2016–2025
    Figure 72: Pfizer, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
    Figure 73: Pfizer, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2013–2016
    Figure 74: Pfizer, Inc. Sales & Marketing Expenses (US$ Mn) and Y-o-Y Growth (%), 2013–2016

Copyright © Transparency Market Research, Inc. All Rights reserved